Search research articles
Contact Us
Filters
Showing results (971-980 of 1,057) with videos related to
Page
of 106
Sort By:
Nature Immunology
|
July 13, 2023
Transcription factor EGR2 controls homing and pathogenicity of T<sub>H</sub>17 cells in the central nervous system
Yuanyuan Gao, Yan Wang, Daniel Chauss, et al.
Nature Medicine
|
October 17, 2017
Sympathetic neuron-associated macrophages contribute to obesity by importing and metabolizing norepinephrine
Roksana M Pirzgalska, Elsa Seixas, Jason S Seidman, et al.
Journal of the National Cancer Institute
|
May 12, 2019
Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell Lymphomas
Miguel Gallardo, Prerna Malaney, Marisa J L Aitken, et al.
Nature Immunology
|
November 25, 2025
Neuroepithelial VIP-VIPR1 interactions differentially control enteric type 1 and type 2 immunity
Roksana M Pirzgalska, Beatriz Henriques-Alves, Bruno Raposo, et al.
Nature Biomedical Engineering
|
April 19, 2024
Synthetic cationic helical polypeptides for the stimulation of antitumour innate immune pathways in antigen-presenting cells
DaeYong Lee, Kristin Huntoon, Yifan Wang, et al.
Cell Reports
|
January 12, 2022
Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells
Evan R Abt, Thuc M Le, Amanda M Dann, et al.
Immunity
|
October 8, 2019
Liver-Derived Signals Sequentially Reprogram Myeloid Enhancers to Initiate and Maintain Kupffer Cell Identity
Mashito Sakai, Ty D Troutman, Jason S Seidman, et al.
Science (New York, N.Y.)
|
October 26, 2019
MAIT cells are imprinted by the microbiota in early life and promote tissue repair
Michael G Constantinides, Verena M Link, Samira Tamoutounour, et al.
Immunity
|
May 5, 2020
Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis
Jason S Seidman, Ty D Troutman, Mashito Sakai, et al.
Nature Communications
|
January 31, 2026
Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial
Zev A Wainberg, Jason M Link, Alykhan Premji, et al.
Page
of 106
Search research articles
Search
Showing results (971-980 of 1,057) with videos related to
Sort By:
Page
of 106
Nature Immunology
|
July 13, 2023
Transcription factor EGR2 controls homing and pathogenicity of T<sub>H</sub>17 cells in the central nervous system
Yuanyuan Gao, Yan Wang, Daniel Chauss, et al.
Nature Medicine
|
October 17, 2017
Sympathetic neuron-associated macrophages contribute to obesity by importing and metabolizing norepinephrine
Roksana M Pirzgalska, Elsa Seixas, Jason S Seidman, et al.
Journal of the National Cancer Institute
|
May 12, 2019
Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell Lymphomas
Miguel Gallardo, Prerna Malaney, Marisa J L Aitken, et al.
Nature Immunology
|
November 25, 2025
Neuroepithelial VIP-VIPR1 interactions differentially control enteric type 1 and type 2 immunity
Roksana M Pirzgalska, Beatriz Henriques-Alves, Bruno Raposo, et al.
Nature Biomedical Engineering
|
April 19, 2024
Synthetic cationic helical polypeptides for the stimulation of antitumour innate immune pathways in antigen-presenting cells
DaeYong Lee, Kristin Huntoon, Yifan Wang, et al.
Cell Reports
|
January 12, 2022
Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells
Evan R Abt, Thuc M Le, Amanda M Dann, et al.
Immunity
|
October 8, 2019
Liver-Derived Signals Sequentially Reprogram Myeloid Enhancers to Initiate and Maintain Kupffer Cell Identity
Mashito Sakai, Ty D Troutman, Jason S Seidman, et al.
Science (New York, N.Y.)
|
October 26, 2019
MAIT cells are imprinted by the microbiota in early life and promote tissue repair
Michael G Constantinides, Verena M Link, Samira Tamoutounour, et al.
Immunity
|
May 5, 2020
Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis
Jason S Seidman, Ty D Troutman, Mashito Sakai, et al.
Nature Communications
|
January 31, 2026
Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial
Zev A Wainberg, Jason M Link, Alykhan Premji, et al.
Page
of 106